ID   PPM1A_HUMAN             Reviewed;         382 AA.
AC   P35813; B5BU11; J3KNM0; O75551;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   22-JUL-2015, entry version 162.
DE   RecName: Full=Protein phosphatase 1A;
DE            EC=3.1.3.16;
DE   AltName: Full=Protein phosphatase 2C isoform alpha;
DE            Short=PP2C-alpha;
DE   AltName: Full=Protein phosphatase IA;
GN   Name=PPM1A; Synonyms=PPPM1A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-1).
RX   PubMed=1311954; DOI=10.1016/0167-4781(92)90471-B;
RA   Mann D.J., Campbell D.G., McGowan C.H., Cohen P.T.W.;
RT   "Mammalian protein serine/threonine phosphatase 2C: cDNA cloning and
RT   comparative analysis of amino acid sequences.";
RL   Biochim. Biophys. Acta 1130:100-104(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-2).
RX   PubMed=9707433; DOI=10.1093/emboj/17.16.4744;
RA   Takekawa M., Maeda T., Saito H.;
RT   "Protein phosphatase 2Calpha inhibits the human stress-responsive p38
RT   and JNK MAPK pathways.";
RL   EMBO J. 17:4744-4752(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-1).
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in
RT   vitro-expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-1).
RC   TISSUE=Colon, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH SMAD2 AND SMAD3, FUNCTION, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF ASP-239.
RX   PubMed=16751101; DOI=10.1016/j.cell.2006.03.044;
RA   Lin X., Duan X., Liang Y.Y., Su Y., Wrighton K.H., Long J., Hu M.,
RA   Davis C.M., Wang J., Brunicardi F.C., Shi Y., Chen Y.G., Meng A.,
RA   Feng X.H.;
RT   "PPM1A functions as a Smad phosphatase to terminate TGFbeta
RT   signaling.";
RL   Cell 125:915-928(2006).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH IKBKB.
RX   PubMed=18930133; DOI=10.1016/j.cellsig.2008.09.012;
RA   Sun W., Yu Y., Dotti G., Shen T., Tan X., Savoldo B., Pass A.K.,
RA   Chu M., Zhang D., Lu X., Fu S., Lin X., Yang J.;
RT   "PPM1A and PPM1B act as IKKbeta phosphatases to terminate TNFalpha-
RT   induced IKKbeta-NF-kappaB activation.";
RL   Cell. Signal. 21:95-102(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   MYRISTOYLATION AT GLY-2.
RX   PubMed=20213681; DOI=10.1002/pmic.200900783;
RA   Suzuki T., Moriya K., Nagatoshi K., Ota Y., Ezure T., Ando E.,
RA   Tsunasawa S., Utsumi T.;
RT   "Strategy for comprehensive identification of human N-myristoylated
RT   proteins using an insect cell-free protein synthesis system.";
RL   Proteomics 10:1780-1793(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=22781750; DOI=10.1016/j.cellsig.2012.07.003;
RA   Bruce D.L., Macartney T., Yong W., Shou W., Sapkota G.P.;
RT   "Protein phosphatase 5 modulates SMAD3 function in the transforming
RT   growth factor-? pathway.";
RL   Cell. Signal. 24:1999-2006(2012).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS).
RX   PubMed=9003755;
RA   Das A.K., Helps N.R., Cohen P.T.W., Barford D.;
RT   "Crystal structure of the protein serine/threonine phosphatase 2C at
RT   2.0-A resolution.";
RL   EMBO J. 15:6798-6809(1996).
CC   -!- FUNCTION: Enzyme with a broad specificity. Negatively regulates
CC       TGF-beta signaling through dephosphorylating SMAD2 and SMAD3,
CC       resulting in their dissociation from SMAD4, nuclear export of the
CC       SMADs and termination of the TGF-beta-mediated signaling.
CC       Dephosphorylates PRKAA1 and PRKAA2. Plays an important role in the
CC       termination of TNF-alpha-mediated NF-kappa-B activation through
CC       dephosphorylating and inactivating IKBKB/IKKB.
CC       {ECO:0000269|PubMed:16751101, ECO:0000269|PubMed:18930133}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC       Note=Binds 2 magnesium or manganese ions per subunit.;
CC   -!- SUBUNIT: Monomer. Interacts with SMAD2; the interaction
CC       dephosphorylates SMAD2 in its C-terminal SXS motif resulting in
CC       disruption of the SMAD2/SMAD4 complex, SMAD2 nuclear export and
CC       termination of the TGF-beta-mediated signaling. Interacts with
CC       SMAD2; the interaction dephosphorylates SMAD2 in its C-terminal
CC       SXS motif resulting in disruption of the SMAD2/SMAD4 complex,
CC       SMAD2 nuclear export and termination of the TGF-beta-mediated
CC       signaling. Interacts with the phosphorylated form of IKBKB/IKKB.
CC       {ECO:0000269|PubMed:16751101, ECO:0000269|PubMed:18930133}.
CC   -!- INTERACTION:
CC       P49407:ARRB1; NbExp=4; IntAct=EBI-989143, EBI-743313;
CC       P32121:ARRB2; NbExp=3; IntAct=EBI-989143, EBI-714559;
CC       O15169:AXIN1; NbExp=2; IntAct=EBI-989143, EBI-710484;
CC       P28482:MAPK1; NbExp=19; IntAct=EBI-989143, EBI-959949;
CC       Q16539:MAPK14; NbExp=2; IntAct=EBI-989143, EBI-73946;
CC       Q9H6Z4:RANBP3; NbExp=4; IntAct=EBI-989143, EBI-992681;
CC       Q15796:SMAD2; NbExp=2; IntAct=EBI-989143, EBI-1040141;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm, cytosol. Membrane
CC       {ECO:0000250}. Note=Weakly associates at the membrane and N-
CC       myristoylation mediates the membrane localization. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=Alpha-1;
CC         IsoId=P35813-1; Sequence=Displayed;
CC       Name=Alpha-2;
CC         IsoId=P35813-2; Sequence=VSP_005085, VSP_005086;
CC       Name=3;
CC         IsoId=P35813-3; Sequence=VSP_045687;
CC         Note=No experimental confirmation available. Ref.3 (AK097843)
CC         sequence is in conflict in position: 54:Q->R. {ECO:0000305};
CC   -!- PTM: N-myristoylation is essential for the recognition of its
CC       substrates for dephosphorylation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the PP2C family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 PPM-type phosphatase domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU01082}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S87759; AAB21784.1; -; mRNA.
DR   EMBL; AF070670; AAC28354.1; -; mRNA.
DR   EMBL; AK097843; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AB451247; BAG70061.1; -; mRNA.
DR   EMBL; AL132778; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL157756; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW80774.1; -; Genomic_DNA.
DR   EMBL; BC026691; AAH26691.1; -; mRNA.
DR   EMBL; BC063243; AAH63243.1; -; mRNA.
DR   CCDS; CCDS45120.1; -. [P35813-3]
DR   CCDS; CCDS9744.1; -. [P35813-1]
DR   CCDS; CCDS9745.1; -. [P35813-2]
DR   PIR; S22423; S22423.
DR   RefSeq; NP_066283.1; NM_021003.4. [P35813-1]
DR   RefSeq; NP_808820.1; NM_177951.2. [P35813-2]
DR   RefSeq; NP_808821.2; NM_177952.2. [P35813-3]
DR   RefSeq; XP_005267836.1; XM_005267779.1. [P35813-1]
DR   RefSeq; XP_005267838.1; XM_005267781.1. [P35813-1]
DR   RefSeq; XP_006720242.1; XM_006720179.1. [P35813-1]
DR   RefSeq; XP_011535180.1; XM_011536878.1. [P35813-1]
DR   RefSeq; XP_011535181.1; XM_011536879.1. [P35813-1]
DR   RefSeq; XP_011535182.1; XM_011536880.1. [P35813-1]
DR   RefSeq; XP_011535183.1; XM_011536881.1. [P35813-1]
DR   RefSeq; XP_011535184.1; XM_011536882.1. [P35813-1]
DR   RefSeq; XP_011535185.1; XM_011536883.1. [P35813-1]
DR   RefSeq; XP_011535186.1; XM_011536884.1. [P35813-1]
DR   UniGene; Hs.130036; -.
DR   PDB; 1A6Q; X-ray; 2.00 A; A=1-382.
DR   PDB; 3FXJ; X-ray; 2.50 A; A=1-382.
DR   PDB; 3FXK; X-ray; 2.10 A; A=1-382.
DR   PDB; 3FXL; X-ray; 2.30 A; A=1-382.
DR   PDB; 3FXM; X-ray; 2.50 A; A=1-382.
DR   PDB; 3FXO; X-ray; 2.50 A; A=1-382.
DR   PDB; 4RA2; X-ray; 1.94 A; A=2-368.
DR   PDBsum; 1A6Q; -.
DR   PDBsum; 3FXJ; -.
DR   PDBsum; 3FXK; -.
DR   PDBsum; 3FXL; -.
DR   PDBsum; 3FXM; -.
DR   PDBsum; 3FXO; -.
DR   PDBsum; 4RA2; -.
DR   ProteinModelPortal; P35813; -.
DR   SMR; P35813; 2-368.
DR   BioGrid; 111489; 26.
DR   IntAct; P35813; 23.
DR   MINT; MINT-2802996; -.
DR   STRING; 9606.ENSP00000327255; -.
DR   BindingDB; P35813; -.
DR   ChEMBL; CHEMBL2437; -.
DR   DEPOD; P35813; -.
DR   PhosphoSite; P35813; -.
DR   BioMuta; PPM1A; -.
DR   DMDM; 548442; -.
DR   MaxQB; P35813; -.
DR   PaxDb; P35813; -.
DR   PeptideAtlas; P35813; -.
DR   PRIDE; P35813; -.
DR   DNASU; 5494; -.
DR   Ensembl; ENST00000325642; ENSP00000327255; ENSG00000100614. [P35813-3]
DR   Ensembl; ENST00000325658; ENSP00000314850; ENSG00000100614. [P35813-2]
DR   Ensembl; ENST00000395076; ENSP00000378514; ENSG00000100614.
DR   GeneID; 5494; -.
DR   KEGG; hsa:5494; -.
DR   UCSC; uc001xex.4; human. [P35813-2]
DR   UCSC; uc001xey.4; human. [P35813-1]
DR   CTD; 5494; -.
DR   GeneCards; GC14P060712; -.
DR   HGNC; HGNC:9275; PPM1A.
DR   HPA; HPA029209; -.
DR   MIM; 606108; gene.
DR   neXtProt; NX_P35813; -.
DR   PharmGKB; PA33603; -.
DR   eggNOG; COG0631; -.
DR   GeneTree; ENSGT00740000115384; -.
DR   HOGENOM; HOG000233895; -.
DR   HOVERGEN; HBG053647; -.
DR   InParanoid; P35813; -.
DR   KO; K04457; -.
DR   OMA; PEVYAIE; -.
DR   OrthoDB; EOG7WMCJH; -.
DR   PhylomeDB; P35813; -.
DR   TreeFam; TF313590; -.
DR   BRENDA; 3.1.3.16; 2681.
DR   Reactome; REACT_121111; Downregulation of SMAD2/3:SMAD4 transcriptional activity.
DR   Reactome; REACT_21285; Regulation of AMPK activity via LKB1.
DR   SignaLink; P35813; -.
DR   ChiTaRS; PPM1A; human.
DR   EvolutionaryTrace; P35813; -.
DR   GeneWiki; PPM1A; -.
DR   GenomeRNAi; 5494; -.
DR   NextBio; 21242; -.
DR   PRO; PR:P35813; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; P35813; -.
DR   CleanEx; HS_PPM1A; -.
DR   ExpressionAtlas; P35813; baseline and differential.
DR   Genevisible; P35813; HS.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; IEA:Ensembl.
DR   GO; GO:0033192; F:calmodulin-dependent protein phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0030145; F:manganese ion binding; IEA:InterPro.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0070412; F:R-SMAD binding; IPI:UniProtKB.
DR   GO; GO:0004871; F:signal transducer activity; IMP:UniProtKB.
DR   GO; GO:0007050; P:cell cycle arrest; TAS:Reactome.
DR   GO; GO:0016311; P:dephosphorylation; IDA:BHF-UCL.
DR   GO; GO:0010467; P:gene expression; TAS:Reactome.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006499; P:N-terminal protein myristoylation; ISS:UniProtKB.
DR   GO; GO:0030514; P:negative regulation of BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB.
DR   GO; GO:0042347; P:negative regulation of NF-kappaB import into nucleus; IMP:UniProtKB.
DR   GO; GO:0010991; P:negative regulation of SMAD protein complex assembly; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0035970; P:peptidyl-threonine dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB.
DR   GO; GO:0046827; P:positive regulation of protein export from nucleus; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0030177; P:positive regulation of Wnt signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0006470; P:protein dephosphorylation; IMP:UniProtKB.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0006351; P:transcription, DNA-templated; TAS:Reactome.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0016055; P:Wnt signaling pathway; IDA:BHF-UCL.
DR   Gene3D; 1.10.10.430; -; 1.
DR   Gene3D; 3.60.40.10; -; 1.
DR   InterPro; IPR015655; PP2C.
DR   InterPro; IPR000222; PP2C_BS.
DR   InterPro; IPR012911; PP2C_C.
DR   InterPro; IPR001932; PPM-type_phosphatase_dom.
DR   PANTHER; PTHR13832; PTHR13832; 1.
DR   Pfam; PF00481; PP2C; 1.
DR   Pfam; PF07830; PP2C_C; 1.
DR   SMART; SM00331; PP2C_SIG; 1.
DR   SMART; SM00332; PP2Cc; 1.
DR   SUPFAM; SSF81601; SSF81601; 1.
DR   SUPFAM; SSF81606; SSF81606; 1.
DR   PROSITE; PS01032; PPM_1; 1.
DR   PROSITE; PS51746; PPM_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Hydrolase; Lipoprotein; Magnesium; Manganese; Membrane; Metal-binding;
KW   Myristate; Nucleus; Phosphoprotein; Protein phosphatase;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    382       Protein phosphatase 1A.
FT                                /FTId=PRO_0000057741.
FT   DOMAIN       23    291       PPM-type phosphatase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01082}.
FT   METAL        60     60       Manganese 1.
FT   METAL        60     60       Manganese 2.
FT   METAL        61     61       Manganese 1; via carbonyl oxygen.
FT   METAL       239    239       Manganese 2.
FT   METAL       282    282       Manganese 2.
FT   MOD_RES     375    375       Phosphoserine.
FT                                {ECO:0000269|PubMed:19690332}.
FT   LIPID         2      2       N-myristoyl glycine.
FT                                {ECO:0000269|PubMed:20213681}.
FT   VAR_SEQ       1      1       M -> MFCSGRKWVAEATICTKLMKREKRRMGKRRAKKAKR
FT                                EEKKKGGERRRNEKRGNQMKRMCERKKYETDLEDQDIM
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045687.
FT   VAR_SEQ     318    324       EIIKKQG -> GGSFNKK (in isoform Alpha-2).
FT                                {ECO:0000303|PubMed:9707433}.
FT                                /FTId=VSP_005085.
FT   VAR_SEQ     325    382       Missing (in isoform Alpha-2).
FT                                {ECO:0000303|PubMed:9707433}.
FT                                /FTId=VSP_005086.
FT   MUTAGEN     239    239       D->N: No effect on binding SMAD2.
FT                                {ECO:0000269|PubMed:16751101}.
FT   CONFLICT    342    342       I -> T (in Ref. 3; AK097843).
FT                                {ECO:0000305}.
FT   STRAND        4      9       {ECO:0000244|PDB:3FXJ}.
FT   STRAND       13     19       {ECO:0000244|PDB:4RA2}.
FT   STRAND       22     29       {ECO:0000244|PDB:4RA2}.
FT   STRAND       33     35       {ECO:0000244|PDB:4RA2}.
FT   STRAND       38     46       {ECO:0000244|PDB:4RA2}.
FT   TURN         47     49       {ECO:0000244|PDB:4RA2}.
FT   STRAND       50     65       {ECO:0000244|PDB:4RA2}.
FT   HELIX        66     80       {ECO:0000244|PDB:4RA2}.
FT   TURN         83     86       {ECO:0000244|PDB:4RA2}.
FT   STRAND       88     91       {ECO:0000244|PDB:4RA2}.
FT   HELIX        94    118       {ECO:0000244|PDB:4RA2}.
FT   STRAND      129    134       {ECO:0000244|PDB:4RA2}.
FT   STRAND      136    146       {ECO:0000244|PDB:4RA2}.
FT   STRAND      148    153       {ECO:0000244|PDB:4RA2}.
FT   STRAND      156    160       {ECO:0000244|PDB:4RA2}.
FT   HELIX       169    177       {ECO:0000244|PDB:4RA2}.
FT   TURN        188    190       {ECO:0000244|PDB:4RA2}.
FT   HELIX       200    202       {ECO:0000244|PDB:4RA2}.
FT   HELIX       210    212       {ECO:0000244|PDB:4RA2}.
FT   STRAND      213    216       {ECO:0000244|PDB:4RA2}.
FT   STRAND      220    225       {ECO:0000244|PDB:4RA2}.
FT   TURN        228    230       {ECO:0000244|PDB:4RA2}.
FT   STRAND      231    237       {ECO:0000244|PDB:4RA2}.
FT   HELIX       239    242       {ECO:0000244|PDB:4RA2}.
FT   HELIX       247    258       {ECO:0000244|PDB:4RA2}.
FT   HELIX       264    277       {ECO:0000244|PDB:4RA2}.
FT   STRAND      284    290       {ECO:0000244|PDB:4RA2}.
FT   HELIX       299    319       {ECO:0000244|PDB:4RA2}.
FT   HELIX       330    339       {ECO:0000244|PDB:4RA2}.
FT   TURN        347    350       {ECO:0000244|PDB:4RA2}.
FT   HELIX       351    354       {ECO:0000244|PDB:4RA2}.
FT   HELIX       355    365       {ECO:0000244|PDB:4RA2}.
SQ   SEQUENCE   382 AA;  42448 MW;  D48EF508B4A76687 CRC64;
     MGAFLDKPKM EKHNAQGQGN GLRYGLSSMQ GWRVEMEDAH TAVIGLPSGL ESWSFFAVYD
     GHAGSQVAKY CCEHLLDHIT NNQDFKGSAG APSVENVKNG IRTGFLEIDE HMRVMSEKKH
     GADRSGSTAV GVLISPQHTY FINCGDSRGL LCRNRKVHFF TQDHKPSNPL EKERIQNAGG
     SVMIQRVNGS LAVSRALGDF DYKCVHGKGP TEQLVSPEPE VHDIERSEED DQFIILACDG
     IWDVMGNEEL CDFVRSRLEV TDDLEKVCNE VVDTCLYKGS RDNMSVILIC FPNAPKVSPE
     AVKKEAELDK YLECRVEEII KKQGEGVPDL VHVMRTLASE NIPSLPPGGE LASKRNVIEA
     VYNRLNPYKN DDTDSTSTDD MW
//
